PL2252273T3 - Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny - Google Patents

Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny

Info

Publication number
PL2252273T3
PL2252273T3 PL09722351T PL09722351T PL2252273T3 PL 2252273 T3 PL2252273 T3 PL 2252273T3 PL 09722351 T PL09722351 T PL 09722351T PL 09722351 T PL09722351 T PL 09722351T PL 2252273 T3 PL2252273 T3 PL 2252273T3
Authority
PL
Poland
Prior art keywords
diuretic
pharmaceutical composition
receptor antagonist
solid pharmaceutical
peptide angiotensin
Prior art date
Application number
PL09722351T
Other languages
English (en)
Inventor
Sunil R. Mhase
Ganesh V. Gat
Jawed Hussain
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40589972&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2252273(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of PL2252273T3 publication Critical patent/PL2252273T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09722351T 2008-03-19 2009-03-17 Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny PL2252273T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN700DE2008 2008-03-19
EP09722351.5A EP2252273B1 (en) 2008-03-19 2009-03-17 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic

Publications (1)

Publication Number Publication Date
PL2252273T3 true PL2252273T3 (pl) 2017-07-31

Family

ID=40589972

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09722351T PL2252273T3 (pl) 2008-03-19 2009-03-17 Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny

Country Status (8)

Country Link
US (1) US20110008428A1 (pl)
EP (1) EP2252273B1 (pl)
CA (1) CA2715350C (pl)
EA (1) EA201001312A1 (pl)
ES (1) ES2623329T3 (pl)
PL (1) PL2252273T3 (pl)
SI (1) SI2252273T1 (pl)
WO (1) WO2009115301A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2252273T3 (pl) 2008-03-19 2017-07-31 Ratiopharm Gmbh Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny
GB0822171D0 (en) * 2008-12-04 2009-01-14 Arrow Int Ltd Temisartan formulations
WO2010075347A2 (en) * 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
TR201004754A1 (tr) * 2010-06-11 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Yeni Farmasötik Kombinasyonlar
CN103169697A (zh) * 2011-12-23 2013-06-26 天津泰普医药知识产权流转储备中心有限公司 包含坎地沙坦或其酯以及氯噻酮的药物组合物及其应用
EP2612658A1 (en) 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
BR102013028883A2 (pt) * 2013-11-08 2015-10-06 Hypermarcas S A forma farmacêutica oral para a prevenção de doenças vasculares, comprimido como forma farmacêutica e cápsula gelatinosa como forma farmacêutica
JP6428340B2 (ja) * 2014-05-23 2018-11-28 ニプロ株式会社 テルミサルタンを含む医薬組成物の造粒方法
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK8603837A (pl) * 1985-08-13 1987-02-14
DE59202126D1 (de) * 1991-07-01 1995-06-14 Gergely Gerhard Verfahren zur Herstellung einer pharmazeutischen Zubereitung mit wenigstens zwei verschiedenen Wirkstoffen und Verwendung einer solchen Zubereitung.
FR2766708B1 (fr) 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US6358986B1 (en) * 1999-01-19 2002-03-19 Boehringer Ingelheim Pharma Kg Polymorphs of telmisartan
PT1467712E (pt) * 2002-01-16 2008-01-09 Boehringer Ingelheim Pharma Comprimido farmacêutico de duas camadas compreendendo telmisartan e hidroclorotiazida
US8980870B2 (en) * 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
WO2005082329A2 (en) * 2004-02-19 2005-09-09 Ranbaxy Laboratories Limited Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide
DE102004008804A1 (de) 2004-02-20 2005-09-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mehrschichttablette
AU2005315855A1 (en) 2004-12-17 2006-06-22 Boehringer Ingelheim International Gmbh Combination therapy comprising telmisartan and hydrochlorothiazide
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
CA2654890C (en) 2006-06-16 2015-10-06 Lek Pharmaceuticals D.D. Pharmaceutical composition
US20100247649A1 (en) * 2007-10-30 2010-09-30 Dr. Reddy's Laboratories Ltd. Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
PL2252273T3 (pl) 2008-03-19 2017-07-31 Ratiopharm Gmbh Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny

Also Published As

Publication number Publication date
EA201001312A1 (ru) 2011-04-29
SI2252273T1 (sl) 2017-06-30
CA2715350A1 (en) 2009-09-24
CA2715350C (en) 2017-02-14
EP2252273B1 (en) 2016-12-28
WO2009115301A1 (en) 2009-09-24
EP2252273A1 (en) 2010-11-24
US20110008428A1 (en) 2011-01-13
ES2623329T3 (es) 2017-07-11

Similar Documents

Publication Publication Date Title
SI2252273T1 (sl) Trdni farmacevtski sestavek, ki obsega nepeptidni antagonist receptorja angiotenzina II in diuretik
HUS2100003I1 (hu) Angiotenzin receptor antagonista és NEP inhibitor gyógyszerészeti kombinációja
EP2244575A4 (en) ANTAGONISTS OF THE ANGIOTENSIN II RECEPTOR
IL229507A0 (en) Extrinsic opioid receptor antagonists and their uses
IL201262A0 (en) Gonadotropin-releasing hormone receptor antagonists and uses thereof
HK1244687A1 (zh) 治療腎小球硬化症的二苯基磺酰胺內皮素和血管緊張素ii受體拮抗劑
HRP20150661T1 (en) Peripheral opioid receptor and antagonists and uses thereof
PL2137191T3 (pl) Antagoniści obwodowego receptora opioidowego i ich zastosowania
IL212599A0 (en) Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic
HK1136302A1 (en) Progesterone receptor antagonists
EP1874302A4 (en) ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
EP2365749A4 (en) QUINOLONE ANTAGONISTS OF THE NEUROPEPTIDE S RECEPTOR
EP2191830A4 (en) SOLID PREPARATION COMPRISING A NPYY5 RECEPTOR ANTAGONIST
EP2254413A4 (en) IMIDAZOBENZAZEPIN-CGRP receptor antagonists
EP2125724A4 (en) NAPHTHALENE DERIVATIVES AND QUINOLINE SULFONYLUREA AS ANTAGONISTS OF THE EP4 RECEPTOR
EP2271346A4 (en) ANTAGONISTS OF MONOCYCLIC CGRP RECEPTORS
EP2365748A4 (en) IMIDAZOISOINDOLA ANTAGONISTS OF NEUROPEPTIDE S RECEPTORS
IL205949A0 (en) 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
ZA200904479B (en) Nitroderivatives as angiotensin II receptor antagonists
EP2341919A4 (en) CGRP RECEPTOR ANTAGONISTS
EP2340025A4 (en) CGRP RECEPTOR ANTAGONISTS
EP2250168A4 (en) ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
EP2331101A4 (en) MONOCYCLIC AMIDE CGRP RECEPTOR ANTAGONISTS
EP2291076A4 (en) Angiotensin-II Receptor Antagonists
GB0701632D0 (en) MET receptor antagonists